
AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference. The Bio-Europe …
Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

